US Broker Ratings

Indivior PLC (INDV) Stock Analysis: Exploring a 20% Upside Potential in the Healthcare Sector

Indivior PLC (NASDAQ: INDV), a key player in the healthcare sector, has been making waves with its specialized focus on developing treatments for opioid dependence and related disorders. With a..

Ligand Pharmaceuticals (LGND) Stock Analysis: Exploring Healthcare Innovation and Market Dynamics

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a compelling player in the biotechnology sector, presenting a diverse portfolio of biopharmaceutical assets that captivates investors with its strategic innovations and market..

Phreesia, Inc. (PHR) Stock Analysis: Unpacking a 47% Upside Potential for Investors

Phreesia, Inc. (PHR), a notable player in the Healthcare sector, is attracting attention from investors with its compelling growth narrative and a significant upside potential. As a provider of SaaS-based..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Biotech Player with a Promising 213% Upside Potential

Investors seeking opportunities in the biotechnology sector may find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) an intriguing prospect. With a market capitalization of $993.2 million, this San Diego-based biopharmaceutical company is..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Powerhouse with 740% Revenue Growth and Strong Buy Ratings

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a Netherlands-based biotechnology firm, stands out in the healthcare sector with its promising therapeutic developments and impressive revenue growth figures. As a late-stage biopharmaceutical..

Addus HomeCare Corporation (ADUS) Stock Analysis: A 16.87% Potential Upside in the Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $2.24 billion, Addus HomeCare operates..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 24.84% Potential Upside

Alphatec Holdings, Inc. (ATEC), a key player in the healthcare sector with a focus on medical devices, is capturing investor attention with its innovative approach to tackling spinal disorders. Headquartered..

Premier, Inc. (PINC) Stock Analysis: Navigating Stability in Healthcare with a Steady Dividend Yield

Premier, Inc. (NASDAQ: PINC) stands as a noteworthy player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.32 billion, Premier, Inc. offers..

Adaptive Biotechnologies (ADPT): Stock Analysis Reveals Strong Revenue Growth Amid Challenging Valuation

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands at the intersection of healthcare and biotechnology, with a focus on decoding the immune system to advance the diagnosis and treatment of various diseases...

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Eyeing a 22% Upside Potential with Strong Buy Ratings

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is currently drawing significant attention from investors, and for good reason. With a market capitalization of $3.22 billion, this U.S.-based healthcare company is making waves..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Biotechnology Innovator with 65.61% Potential Upside

Investors with an eye on the biotechnology sector should keep Apogee Therapeutics, Inc. (APGE) on their radar. This clinical-stage company, headquartered in Waltham, Massachusetts, is making strides in developing biologics..

Travere Therapeutics, Inc. (TVTX) Investor Outlook: Strong Buy Ratings and Promising 28.82% Potential Upside

Travere Therapeutics, Inc. (TVTX), a prominent player in the biotechnology sector, is capturing investor attention with its robust pipeline of therapies targeting rare kidney and metabolic diseases. With a market..

Alvotech (ALVO) Stock Analysis: Unpacking Potential 103.73% Upside in Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based innovator in the biosimilar drug manufacturing sector, presents itself as a compelling opportunity for investors, particularly those with an eye on the healthcare industry’s evolving..

Certara, Inc. (CERT) Stock Analysis: Navigating a 19.82% Potential Upside in the Healthcare Sector

Certara, Inc. (NASDAQ: CERT) stands as a formidable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $1.98 billion, Certara has positioned..

PACS Group, Inc. (PACS): Analyst Ratings Reveal 173% Potential Upside for Healthcare Investors

For investors seeking opportunities in the healthcare sector, PACS Group, Inc. (PACS) offers a compelling narrative. Operating within the medical care facilities industry, PACS Group is strategically positioned in the..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech with 192% Potential Upside in Cancer Immunotherapy

Janux Therapeutics, Inc. (NASDAQ: JANX) is capturing significant investor attention in the biotechnology sector, fueled by its innovative approach to cancer immunotherapy and a stunning potential upside of 192% based..

Sotera Health Company (SHC) Stock Analysis: Navigating a Strong Market Cap and Promising Revenue Growth

Sotera Health Company (NASDAQ: SHC), a pivotal player in the healthcare sector’s diagnostics and research industry, has attracted significant attention from investors. Headquartered in Broadview Heights, Ohio, Sotera Health offers..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on a Biotech with 14.4% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has captured the attention of investors with its promising portfolio of innovative therapies targeting rare and orphan diseases. With a market capitalization of $3.69 billion,..

Galapagos NV (GLPG) Stock Analysis: Navigating a Challenging Biotech Landscape Amidst a 26.12% Potential Downside

Galapagos NV (GLPG), a biotechnology company with a focus on oncology and immunology, is navigating a complex and competitive landscape within the healthcare sector. Headquartered in Mechelen, Belgium, Galapagos operates..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Unveiling a Potential 102% Upside in the Biotech Sector

Dyne Therapeutics, Inc. (NASDAQ: DYN), a fascinating player in the biotechnology sector, offers investors a unique opportunity to explore a company focused on pioneering therapies for neuromuscular diseases. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds